Keymed Biosciences Inc. (HKG: 2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
42.05
+0.20 (0.48%)
Oct 10, 2024, 4:08 PM HKT

Keymed Biosciences Revenue

Keymed Biosciences had revenue of 54.68M CNY in the half year ending June 30, 2024, a decrease of -45.32%. This brings the company's revenue in the last twelve months to 81.65M, down -75.04% year-over-year. In the year 2023, Keymed Biosciences had annual revenue of 354.10M with 253.87% growth.

Revenue (ttm)
81.65M CNY
Revenue Growth
-75.04%
P/S Ratio
125.33
Revenue / Employee
88.08K CNY
Employees
927
Market Cap
11.59B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023354.10M254.03M253.87%
Dec 31, 2022100.06M-10.21M-9.26%
Dec 31, 2021110.27M--
Dec 31, 2020---
Dec 31, 2019---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition